Results 201 to 210 of about 68,978 (241)

ESGE/ESGO/SERGS consensus statement on surgical steps in minimally invasive surgery in gynecologic oncology: transperitoneal and extraperitioneal approach for paraaortic lymphadenectomy. [PDF]

Int J Gynecol Cancer
Rovira R, Mereu L, Planchamp F, Falconer H, El-Balat A, Barahona M, Fagotti A, Querleu D, Taskiran C.   +8 more
europepmc   +1 more source

Determinants of surgical department research success

ANZ Journal of Surgery, EarlyView.
Daniel Steffens, Michael Solomon, Sascha Karunaratne, Kate Alexander, Charbel Sandroussi, Kate McBride, Sophie Hogan, Sharon Carey, Jonathan Clark   +8 more
wiley   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Gynecologic oncology in pregnancy

Critical Reviews in Oncology/Hematology, 2008
In this review current knowledge on prevalence, diagnosis, treatment and prognosis of gynaecological malignancies during pregnancy is discussed. After a general overview of surgery, chemotherapy and radiotherapy during pregnancy, tumor specific diagnosis and treatment options are described for breast, cervical, ovarian, endometrial and vulvar cancer ...
Amant, F., Calsteren, K. van, Vergote, I., Ottevanger, N.   +3 more
openaire   +4 more sources

Laparoscopy and Gynecologic Oncology

Clinical Obstetrics & Gynecology, 2009
Laparoscopy was used for a second-look assessment in ovarian cancer patients back in the 1970s. However, it is only with the advent of new developments in equipment in the late 1980s and early 1990s along with the vision of pioneers in laparoscopic surgery that has made operative laparoscopy in gynecologic oncology feasible.
Jennifer E. Cho, Connie S Liu, Farr Nezhat, Gabrielle Gossner   +3 more
openaire   +3 more sources

Oncogenes in Gynecologic Oncology

Obstetrical & Gynecological Survey, 1996
Advances in molecular biology have facilitated the recent investigation of gynecological malignancies. The presence of certain oncogenes within gynecological tumors indicates that transformation may be associated with genetic alteration of normal regulatory processes.
Maxwell Gl, Carlson Jw
openaire   +3 more sources

Immuno-oncology for Gynecologic Malignancies

2020
Patients with advanced and/or recurrent gynecologic cancers derive limited benefit from currently available cytotoxic and targeted therapies. Successes of immunotherapy in other difficult-to-treat malignancies such as metastatic melanoma and advanced lung cancer have led to intense interest in clinical testing of these treatments in patients with ...
Ami Patel, Jeffrey How, Amir A. Jazaeri
openaire   +4 more sources

Endoscopy in Gynecologic Oncology

2015
Endoscopic surgery offers the advantages of quicker recovery, shorter hospital stay and a lower risk of complications such as infections, blood loss, wound infection, ileus and incisional hernias. The feasibility of endoscopy in gynecological cancer has been shown in numerous papers demonstrating equivalence in terms of radicality.
Tozzi R., Fachechi G., Gubbala K., Cianci S., Campanile R. G., Majd H. S.   +5 more
openaire   +2 more sources

ANTITHROMBOTIC THERAPY IN GYNECOLOGIC SURGERY AND GYNECOLOGIC ONCOLOGY [PDF]

Hematology/Oncology Clinics of North America, 2000
The European Consensus Conference has assessed the risk for thrombotic complications for most women undergoing gynecologic surgery and found it to be moderate. Nonetheless, it is important to analyze a patient's individual risk before surgery so that appropriate thrombosis prophylaxis can be given if increased risk is determined.
Georg-Friedrich von Tempelhoff, L Heilmann   +1 more
openaire   +2 more sources